Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Hims & Hers Health Inc before investing.

In this article, we go over a few key elements for understanding Hims & Hers Health Inc’s stock price such as:

• Hims & Hers Health Inc’s current stock price and volume
• Why Hims & Hers Health Inc’s stock price changed recently
• Upgrades and downgrades for HIMS from analysts
• HIMS’s stock price momentum as measured by its relative strength

About Hims & Hers Health Inc (HIMS)

Before we jump into Hims & Hers Health Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.

Want to learn more about Hims & Hers Health Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Hims & Hers Health Inc.

Hims & Hers Health Inc’s Stock Price as of Market Close

As of September 24, 2024, 4:00 PM, CST, Hims & Hers Health Inc’s stock price was $17.27.

Hims & Hers Health Inc is up 5.05% from its previous closing price of $16.44.

During the last market session, Hims & Hers Health Inc’s stock traded between $16.20 and $16.53. Currently, there are 214.62 million shares of Hims & Hers Health Inc stock available for purchase.

Hims & Hers Health Inc’s price-earnings (P/E) ratio is currently at 219.1, which is high compared to the Pharmaceuticals industry median of 27.4. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Hims & Hers Health Inc Stock Price History

Hims & Hers Health Inc’s (HIMS) price is currently up 17.24% so far this month.

During the month of September, Hims & Hers Health Inc’s stock price has reached a high of $17.29 and a low of $13.47.

Over the last year, Hims & Hers Health Inc has hit prices as high as $25.74 and as low as $5.65. Year to date, Hims & Hers Health Inc’s stock is up 169.42%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Hims & Hers Health Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 23, 2024, there was 1 analyst who downgraded Hims & Hers Health Inc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Hims & Hers Health Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Hims & Hers Health Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Hims & Hers Health Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Hims & Hers Health Inc (HIMS) by visiting AAII Stock Evaluator.

Relative Price Strength of Hims & Hers Health Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 23, 2024, Hims & Hers Health Inc has a weighted four-quarter relative price strength of 14.81%, which translates to a Momentum Score of 90 and is considered to be Very Strong.

Want to learn more about how Hims & Hers Health Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Hims & Hers Health Inc Stock Price: Bottom Line

As of September 24, 2024, Hims & Hers Health Inc’s stock price is $17.27, which is up 5.05% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Hims & Hers Health Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.